
Dihydrofolate reductase
ProteinWikipedia
8
MENTIONS
3
EPISODES
3
PODCASTS
Search complete. 8 mentions across 3 episodes found for "Dihydrofolate reductase".
Nov 5, 2026
Prothrombotic FVIII Mutation and Prime Editing T-Cells for Drug Resistance
T
24:00Thomas LewGUEST
With tacrolimus, this requires FKBP12, the protein, or at the gene level, FKBP1A, and simply deletion of that gene is sufficient to confer resistance to tacrolimus, and that doesn't appear to have any deleterious effects on the T cell.
T
24:17Thomas LewGUEST
It seems like the only biological purpose for FKBP1A is really to serve as a drug-binding ligand, whereas DHFR or IMDPH2 These are genes that have important biological roles.
T
24:30Thomas LewGUEST
If you just deleted them, they would actually be more mimicking the action of the drug than conferring resistance.
T
24:35Thomas LewGUEST
So you need something that's more precise, that can confer drug-binding interfering mutations that don't interfere with the function of the gene.
M
25:53Miles HortonGUEST
But even after that stringent selection, we never really saw the percentage editing efficiency of resistant cells increase above 55 to 60%, which to us is really consistent with the idea that these cells need a certain gene dosage in order for tacrolimus to exert its effect.
M
26:12Miles HortonGUEST
And many of these cells would have been biallelically edited, but a proportion would alleles remain in the wild type setting, it's probably the case that those cells are heterozygous and the loss of one copy of FKBP1A is sufficient to confer resistance.
M
26:25Miles HortonGUEST
For DHFR and INPDH2, it more makes sense that autosomal dominant effects would confer resistance because the substrate discrimination problem is revealed if there's just one copy of edited protein.
N
26:39Natalie RosenHOST
Is there anything else that you'd like to share with our listeners today regarding your recent work?
Methylation Explained: MTHFR, B12, Folate and the Genes Almost Nobody Checks
L
8:09Lisa TamatiHOST
And FOLR1 is the doorway that gets the folate into your brain.
L
8:14Lisa TamatiHOST
And then there's a gene called the DHFR, And I want you to remember this one because it's at the heart of why I don't really like folic acid, which is the synthetic substance.
L
8:24Lisa TamatiHOST
form that has been man-made, and I'll come back to it in a little while.
L
8:28Lisa TamatiHOST
Now here's the part almost nobody talks about.
9 MINS LATER
L
17:58Lisa TamatiHOST
Well, if you're eating a lot of those, you're getting a lot of folic acid.
L
18:01Lisa TamatiHOST
Now, the problem is your body has to convert folic acid before it can use it.
L
18:06Lisa TamatiHOST
And the first step relies on that gene I told you to remember before, which was the DHFR gene.
L
18:12Lisa TamatiHOST
Now, in humans, that enzyme is incredibly slow compared with animals.
Dr Clare Craig - Mass Medication Without Consent: Folic Acid Debate
P
17:51Peter McIlvennaHOST
There were two things actually stuck out.
P
17:53Peter McIlvennaHOST
Not only the video you've done on Marmite, but you talk about DHFR.
P
18:01Peter McIlvennaHOST
Yes.
C
18:03Clare CraigGUEST
Dihydrofolate.
C
20:08Clare CraigGUEST
But actually, it turns out all rodents have an amazing enzyme compared with us.
C
20:12Clare CraigGUEST
So our enzymes are 56 times slower than rats.
C
20:15Clare CraigGUEST
And folic acid is processed 1,300 times slower than a natural folate through our DHFR.
C
20:23Clare CraigGUEST
So you get this massive problem with a backlog that isn't forever.